Document Detail


Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
MedLine Citation:
PMID:  6168855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of saralasin infusion on systemic hemodynamics, plasma renin activity (PRA), and aldosterone levels was studied under various conditions of sodium balance in 25 patients with essential hypertension. The results of 66 paired observations were statistically analyzed, to elucidate some controversial aspects of the mechanisms of saralasin action. The total peripheral resistance index (TPRI) increased when saralasin had an agonistic effect on blood pressure (BP) and decreased when it acted as an antagonist. The TPRI changed more than the BP by an inversely directed change in the cardiac index (CI). In addition, the changes in the CI were only weakly correlated with the changes in MAP; CI decreased consistently when BP increased but showed no distinct pattern when saralasin acted as an antagonist. The pulse rate did not change under any of the conditions applied. The present findings suggest that in addition to its antagonistic effects on peripheral circulation, saralasin has some action on the heart and autonomic nervous system. The observed changes in the plasma aldosterone level were in accordance with the changes in TPRI and did not point to a difference between adrenal and vascular sensitivity to saralasin or angiotensin II. The overall hemodynamic responses were related to the existing level of PRA. No correlation was found between the degree of volume depletion and the blood pressure response during saralasin after elimination of the effect of PRA by partial regression analysis. These findings do not support the concept that more information about the renin dependency of the BP is provided by the BP reaction to saralasin than by determination of the PRA.
Authors:
J C Roos; G G Geyskes; P Boer; E J Dorhout Mees
Related Documents :
15250915 - Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implic...
8282375 - Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
2244565 - Effects of renin inhibition in systemic hypertension.
1381795 - The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin sy...
16952095 - Blood pressure effects on retinal vessel diameter and flicker response: a 1.5-year foll...
3902775 - Transmission of airway pressure to pleural space during lung edema and chest wall restr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  3     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1981 Sep-Oct
Date Detail:
Created Date:  1981-11-22     Completed Date:  1981-11-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1106-15     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone / blood
Angiotensin II / analogs & derivatives*,  antagonists & inhibitors*
Blood Pressure / drug effects
Cardiac Output / drug effects
Extracellular Space / drug effects
Heart Rate / drug effects
Hemodynamics / drug effects*
Hormones / blood*
Humans
Renin / blood
Saralasin / pharmacology*
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Hormones; 11128-99-7/Angiotensin II; 34273-10-4/Saralasin; 52-39-1/Aldosterone; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of sulfhydryl groups in aortic responses using N-ethylmaleimide.
Next Document:  Vascular relaxation in the spontaneously hypertensive rat.